周期日、雌激素水平与主导卵泡大小:分析27,790个体外受精周期以确定促性腺激素释放激素拮抗剂的最佳启动标准
该回顾性临床队列分析了27,790个新鲜自体体外受精周期,评估启动GnRH拮抗剂时的周期日、雌二醇(E2)水平和主导卵泡大小对临床妊娠率的影响。结果显示主导卵泡14-15.9 mm、周期第6天或E2 500-599 pg/mL时启动的临床妊娠率最高;E2<300或>1,100 pg/mL时启动降低临床妊娠 odds 40%(OR 0.60)。
要点
- 主导卵泡14-15.9 mm时启动拮抗剂临床妊娠率最高(21.3%,95%CI 19.3-23.6)。
- 周期第6天启动临床妊娠率22.2%(95%CI 17-28.4)。
- E2 500-599 pg/mL启动临床妊娠率25.4%(95%CI 19.5-32.4)。
核心结论
- 启动拮抗剂时的周期日、E2水平和卵泡大小均为体外受精后临床妊娠的独立预测因素。
- E2极低(<300 pg/mL)或极高(>1,100 pg/mL)时启动拮抗剂显著降低妊娠 odds。
研究设计与样本
- 回顾性临床队列研究,纳入接受新鲜自体体外受精、使用GnRH拮抗剂抑制排卵的妇女。
- 分析27,790个周期,测量启动拮抗剂当日的的主导卵泡大小、E2水平和刺激周期日。
主要发现
- 主导卵泡达14-15.9 mm时启动的平均临床妊娠率为21.3%(95%CI 19.3-23.6)。
- 周期第6天启动的平均临床妊娠率为22.2%(95%CI 17-28.4)。
- E2 500-599 pg/mL时启动的平均临床妊娠率为25.4%(95%CI 19.5-32.4)。
- E2<300或>1,100 pg/mL时启动降低临床妊娠 odds 40%(OR 0.60,95%CI 0.5-0.7)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the optimal criteria at which to start GnRH antagonists during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). DESIGN: Retrospective clinical cohort. SETTING: IVF clinics. PATIENT(S): Women undergoing fresh autologous IVF using GnRH antagonist for ovulation suppression during COH. INTERVENTION(S): Measurement of lead follicle size, E2 level, and cycle day of stimulation on day of antagonist initiation. MAIN OUTCOME MEASURE(S): Clinical pregnancy rate (PR). RESULT(S): The highest clinical PR was achieved when the antagonist was started when a lead follicle reached 14-15.9 mm in size (mean clinical PR 21.3; 95% confidence interval [CI] 19.3, 23.6) on cycle day 6 (mean clinical PR 22.2; 95% CI 17, 28.4), or when the E2 level was between 500 and 599 pg/mL (mean clinical PR 25.4; 95% CI 19.5, 32.4). Starting antagonists when the E2 level was <300 or >1,100 pg/mL reduced the odds of clinical pregnancy by 40% (odds ratio 0.60, 95% CI 0.5, 0.7). CONCLUSION(S): Cycle day, E2 level, and follicle size at time of antagonist start are all independent predictors of a clinical pregnancy after IVF. Initiating antagonists when the E2 level is extremely low (<300 pg/mL) or extremely high (>1,100 pg/mL) significantly reduces the odds of pregnancy.
引用
- Lyttle Schumacher BM, Mersereau JE, Steiner AZ, et al. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist. Fertil Steril. 2018. PMID: 29605403. doi:10.1016/j.fertnstert.2017.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。